| Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study D Aarsland, K Brønnick, JP Larsen, OB Tysnes, G Alves neurology 72 (13), 1121-1126, 2009 | 883 | 2009 |
| Epidemiology of Parkinson’s disease G Alves, EB Forsaa, KF Pedersen, M Dreetz Gjerstad, JP Larsen Journal of neurology 255, 18-32, 2008 | 687 | 2008 |
| Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial D Aarsland, C Ballard, Z Walker, F Bostrom, G Alves, K Kossakowski, ... The Lancet Neurology 8 (7), 613-618, 2009 | 588 | 2009 |
| Changes in motor subtype and risk for incident dementia in Parkinson's disease G Alves, JP Larsen, M Emre, T Wentzel‐Larsen, D Aarsland Movement disorders: official journal of the Movement Disorder Society 21 (8 …, 2006 | 536 | 2006 |
| A 12-year population-based study of psychosis in Parkinson disease EB Forsaa, JP Larsen, T Wentzel-Larsen, CG Goetz, GT Stebbins, ... Archives of Neurology 67 (8), 996-1001, 2010 | 424 | 2010 |
| Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study KF Pedersen, JP Larsen, OB Tysnes, G Alves JAMA neurology 70 (5), 580-586, 2013 | 405 | 2013 |
| Epidemiology of psychosis in Parkinson's disease G Fénelon, G Alves Journal of the neurological sciences 289 (1-2), 12-17, 2010 | 386 | 2010 |
| What predicts mortality in Parkinson disease? A prospective population-based long-term study EB Forsaa, JP Larsen, T Wentzel-Larsen, G Alves Neurology 75 (14), 1270-1276, 2010 | 352 | 2010 |
| Progression of motor impairment and disability in Parkinson disease: a population-based study G Alves, T Wentzel-Larsen, D Aarsland, JP Larsen Neurology 65 (9), 1436-1441, 2005 | 346 | 2005 |
| The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease D Aarsland, K Brønnick, G Alves, OB Tysnes, KF Pedersen, U Ehrt, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (8), 928-930, 2009 | 321 | 2009 |
| Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study G Alves, B Müller, K Herlofson, I HogenEsch, W Telstad, D Aarsland, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (8), 851-857, 2009 | 310 | 2009 |
| Is fatigue an independent and persistent symptom in patients with Parkinson disease? G Alves, T Wentzel-Larsen, JP Larsen Neurology 63 (10), 1908-1911, 2004 | 298 | 2004 |
| Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease JH Friedman, G Alves, P Hagell, J Marinus, L Marsh, P Martinez‐Martin, ... Movement Disorders 25 (7), 805-822, 2010 | 272 | 2010 |
| CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study G Alves, K Brønnick, D Aarsland, K Blennow, H Zetterberg, C Ballard, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (10), 1080-1086, 2010 | 251 | 2010 |
| Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study KF Pedersen, JP Larsen, G Alves, D Aarsland Parkinsonism & related disorders 15 (4), 295-299, 2009 | 247 | 2009 |
| Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? MD Gjerstad, G Alves, T Wentzel-Larsen, D Aarsland, JP Larsen Neurology 67 (5), 853-858, 2006 | 246 | 2006 |
| Predictors and course of health‐related quality of life in Parkinson's disease EB Forsaa, JP Larsen, T Wentzel‐Larsen, K Herlofson, G Alves Movement disorders: official journal of the Movement Disorder Society 23 (10 …, 2008 | 238 | 2008 |
| Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study KF Pedersen, JP Larsen, OB Tysnes, G Alves Neurology 88 (8), 767-774, 2017 | 220 | 2017 |
| CSF Aβ42 predicts early-onset dementia in Parkinson disease G Alves, J Lange, K Blennow, H Zetterberg, U Andreasson, MG Førland, ... Neurology 82 (20), 1784-1790, 2014 | 190 | 2014 |
| Cellular proteostasis in neurodegeneration A Kurtishi, B Rosen, KS Patil, GW Alves, SG Møller Molecular neurobiology 56, 3676-3689, 2019 | 177 | 2019 |
